Yanhong Shang

980 total citations
43 papers, 574 citations indexed

About

Yanhong Shang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yanhong Shang has authored 43 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Yanhong Shang's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Yanhong Shang is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Yanhong Shang collaborates with scholars based in China, Germany and United States. Yanhong Shang's co-authors include Xiang‐Dang Du, Aimin Zang, Zheng Yin, Štefan Schwarz, Yiqiang Chen, Dexi Li, Xiangmei Li, Kun Ge, Sumei Zhang and Xinxin Shan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Yanhong Shang

42 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanhong Shang China 15 202 95 90 75 74 43 574
Johannes F. Wentzel South Africa 14 463 2.3× 223 2.3× 43 0.5× 44 0.6× 90 1.2× 19 802
Henry J. Windle Ireland 21 365 1.8× 76 0.8× 82 0.9× 117 1.6× 87 1.2× 40 1.3k
Ghalia Khoder United Arab Emirates 16 309 1.5× 58 0.6× 129 1.4× 93 1.2× 61 0.8× 31 799
Jiaqi Zhao China 15 305 1.5× 84 0.9× 305 3.4× 39 0.5× 45 0.6× 50 1.1k
Miriam Romano Italy 12 245 1.2× 48 0.5× 84 0.9× 20 0.3× 38 0.5× 19 629
Jinliang Kong China 12 580 2.9× 40 0.4× 82 0.9× 143 1.9× 75 1.0× 55 1.0k
Masataka Oda Japan 17 319 1.6× 37 0.4× 106 1.2× 55 0.7× 28 0.4× 49 815
Shuangqi Cai China 11 390 1.9× 59 0.6× 74 0.8× 70 0.9× 13 0.2× 19 668
Wenjing Wu China 19 504 2.5× 68 0.7× 80 0.9× 34 0.5× 71 1.0× 42 1.2k
Floriana Cappiello Italy 19 544 2.7× 20 0.2× 34 0.4× 75 1.0× 29 0.4× 41 962

Countries citing papers authored by Yanhong Shang

Since Specialization
Citations

This map shows the geographic impact of Yanhong Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhong Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhong Shang more than expected).

Fields of papers citing papers by Yanhong Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhong Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhong Shang. The network helps show where Yanhong Shang may publish in the future.

Co-authorship network of co-authors of Yanhong Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhong Shang. A scholar is included among the top collaborators of Yanhong Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhong Shang. Yanhong Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shang, Yanhong, et al.. (2025). A novel lysin Ply691 exhibits potent bactericidal activity against Streptococcus suis. Frontiers in Veterinary Science. 12. 1653748–1653748.
2.
Li, Wen‐Jun, Shengxiang Ge, Yong Liu, et al.. (2025). Characterization of lincomycin resistance gene lnu(C)-carrying Campylobacter jejuni. Veterinary Microbiology. 310. 110707–110707. 1 indexed citations
3.
Shan, Xinxin, Chenglong Li, Chenhui Zou, et al.. (2024). poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis. Journal of Antimicrobial Chemotherapy. 79(12). 3199–3203. 4 indexed citations
4.
Bai, Lin, Yumiao Li, Xiaofang Wang, et al.. (2024). Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy. Nature Communications. 15(1). 3860–3860. 10 indexed citations
6.
Li, Yumiao, Xiangpeng Gao, Sang‐Won Um, et al.. (2023). Cullin7 induces docetaxel resistance by regulating the protein level of the antiapoptotic protein Survivin in lung adenocarcinoma cells. Journal of Thoracic Disease. 15(9). 5006–5019. 3 indexed citations
7.
Shang, Yanhong, Ran Huo, Xiaofang Li, et al.. (2023). Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients. Frontiers in Oncology. 12. 1064598–1064598. 1 indexed citations
9.
Zheng, Yi, Shiying Hao, Xiang Cheng, et al.. (2021). The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis. Frontiers in Oncology. 11. 592854–592854. 15 indexed citations
10.
Zhang, Yue, et al.. (2021). Emergence of a tet(M) Variant Conferring Resistance to Tigecycline in Streptococcus suis. Frontiers in Veterinary Science. 8. 709327–709327. 14 indexed citations
11.
Shang, Yanhong, Xiaofang Li, Weiwei Liu, et al.. (2020). Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific Reports. 10(1). 20243–20243. 26 indexed citations
12.
Li, Jinghua, et al.. (2020). Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation. The Oncologist. 25(10). 826–832. 3 indexed citations
14.
Liu, Bin, Lixia Liu, Aimin Zang, et al.. (2019). Tanshinone IIA inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via p53‑cyclin B1/CDC2. Oncology Letters. 18(3). 3317–3322. 5 indexed citations
15.
Shang, Yanhong, Dexi Li, Xinxin Shan, et al.. (2019). <p>Analysis of two pheromone-responsive conjugative multiresistance plasmids carrying the novel mobile <em>optrA</em> locus from <em>Enterococcus faecalis</em></p>. Infection and Drug Resistance. Volume 12. 2355–2362. 25 indexed citations
16.
Wang, Yanan, Aimin Zang, Yanhong Shang, et al.. (2018). Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells. Biological Research. 51(1). 2–2. 3 indexed citations
17.
Zhu, Xiaoqing, Xiaoming Wang, Hui Li, et al.. (2016). Novellnu(G) gene conferring resistance to lincomycin by nucleotidylation, located on Tn6260fromEnterococcus faecalisE531. Journal of Antimicrobial Chemotherapy. 72(4). dkw549–dkw549. 20 indexed citations
18.
Yang, Yang�, Aimin Zang, Yanhong Shang, et al.. (2016). Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling. Oncology Letters. 12(3). 2189–2193. 54 indexed citations
19.
Shang, Yanhong, Aimin Zang, Jinghua Li, et al.. (2016). MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Biomedicine & Pharmacotherapy. 83. 1175–1181. 27 indexed citations
20.
Chen, Hong‐Ying, Yanhong Shang, Bao-An Cui, et al.. (2011). Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18. Antiviral Research. 91(1). 50–56. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026